Cell Therapeutics Incorporated (CTIC) Stock Quote
Get the latest CTIC - Cell Therapeutics Incorporated stock market performance data and financial news.
Cell Therapeutics Incorporated (CTIC) Community Sentiment ...
Get the latest CTIC - Cell Therapeutics Incorporated together with stock market performance data and financial news.
Jim Cramer's Take on Cell Therapeutics Incorporated
Read Jim Cramer's take on Cell Therapeutics Incorporated (CTIC) and get his latest thoughts on the company?s performance and outlook
Biotech Stock Mailbag: Cell Therapeutics
Biotech columnist Adam Feuerstein answers reader email about Cell Therapeutics and other stocks.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10643058/1/biotech-stock-mailbag-cell-therapeutics.html
Financial Portfolio on Recent Stock Quotes & Stock Market Picks ...
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
RealMoney.com: TheStreet Notes: A Daily Briefing of Research and ...
... Cell Therapeutics (CTIC / Nasdaq) Warburg Dillon Read We are upgrading
the shares of CTIC to Strong Buy from Buy. Our upgrade is ...
Cell Therapeutics Still Has Heavy Debt Load
Holders of more than half of Cell Therapeutics' debt chose not to accept the company's below-par bid for their notes.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10518117/1/cell-therapeutics-still-has-heavy-debt-load.html
Biotech Mailbag: Cell Thera-Pew-Tics
Investors have a least three huge reasons to avoid this company.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10455786/1/biotech-mailbag-cell-thera-pew-tics.html
Cell Thera Tries Bait-and-Switch With Opaxio
Cell Therapeutics has withdrawn its European approval application for the lung cancer drug Opaxio. But you wouldn't quite get that from the company's statement Monday.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10601453/1/cell-thera-tries-bait-and-switch-with-opaxio.html
Cell Therapeutics Sells Rest of Zevalin Stake
Cell Therapeutics is selling off the remaining 50% stake in its cancer drug Zevalin for $18 million in a desperate bid to keep the company afloat.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10465400/1/cell-therapeutics-sells-rest-of-zevalin-stake.html
Connect with TheStreet